Zobrazeno 1 - 10
of 3 775
pro vyhledávání: '"Fan, S. H."'
Publikováno v:
Journal of Ovonic Research. Sep/Oct2024, Vol. 20 Issue 5, p601-615. 15p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Physics: Conference Series; 2024, Vol. 2878 Issue 1, p1-8, 8p
Autor:
Zhou, T., Lai, Y. S., Yang, Z. H., Shi, Y. H., Luo, X. R., Liu, L., Yu, P., Chen, G., Cao, L. X., Fan, S. H., Cai, C. J., Sun, J., Chen, S. H., Lu, H. Y., Ma, X. L., Li, S. D., Tang, X. L.
Publikováno v:
Journal of Environmental Informatics; Sep2024, Vol. 44 Issue 1, p48-60, 13p
Autor:
Petersiel N; Victorian Infectious Diseases Service, The Royal Melbourne Hospital, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.; Department of Infectious Diseases, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia., Giulieri S; Victorian Infectious Diseases Service, The Royal Melbourne Hospital, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.; Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia., Daniel DS; Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.; Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia., Fan S-H; The Lundquist Institute for Biomedical Innovation, Torrance, California, USA., Ersoy SC; The Lundquist Institute for Biomedical Innovation, Torrance, California, USA., Davis JS; Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia.; Department of Infectious Diseases, John Hunter Hospital, Newcastle, New South Wales, Australia., Bayer AS; The Lundquist Institute for Biomedical Innovation, Torrance, California, USA.; The Geffen School of Medicine, University of California, Los Angeles, California, USA., Howden BP; Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.; Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.; Centre for Pathogen Genomics, The University of Melbourne, Melbourne, Victoria, Australia.; Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia., Tong SYC; Victorian Infectious Diseases Service, The Royal Melbourne Hospital, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.; Department of Infectious Diseases, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 Jul 09; Vol. 68 (7), pp. e0021824. Date of Electronic Publication: 2024 Jun 05.
Autor:
Ersoy SC; The Lundquist Institute for Biomedical Innovations at Harbor-UCLA Medical Center, Torrance, California, USA., Proctor RA; Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.; Department of Medical Microbiology and Immunology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA., Rose WE; School of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin, USA., Abdelhady W; The Lundquist Institute for Biomedical Innovations at Harbor-UCLA Medical Center, Torrance, California, USA., Fan S-H; The Lundquist Institute for Biomedical Innovations at Harbor-UCLA Medical Center, Torrance, California, USA., Madrigal SL; California State University-Los Angeles, Los Angeles, California, USA., Elsayed AM; The Lundquist Institute for Biomedical Innovations at Harbor-UCLA Medical Center, Torrance, California, USA., Chambers HF; University of California-San Francisco School of Medicine, San Francisco, California, USA., Sobral RG; Laboratory of Molecular Microbiology of Bacterial Pathogens, UCIBIO, Applied Molecular Biosciences Unit, Department of Life Sciences, Nova School of Science and Technology, Universidade Nova de Lisboa, Caparica, Portugal.; Associate Laboratory i4HB, Institute for Health and Bioeconomy, Nova School of Science and Technology, Universidade Nova de Lisboa, Caparica, Portugal., Bayer AS; The Lundquist Institute for Biomedical Innovations at Harbor-UCLA Medical Center, Torrance, California, USA.; David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 Mar 06; Vol. 68 (3), pp. e0162723. Date of Electronic Publication: 2024 Feb 13.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.